|Articles|August 1, 2002
Agreement announced: InSite Vision to help find test for PCG detection
Alameda, CA-InSite Vision Inc. has joined forces with an unnamed diagnostics company to develop a commercial assay to detect genetic mutations associated with primary congenital glaucoma (PCG).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5
























